Institutional Ownership Context Therapeutics Inc. (CNTX)
This table provides information about the institutional ownership of Context Therapeutics Inc. (CNTX). We have compiled data on the 55 institutions that hold shares in the stock, with a total of 72.9 Million shares, which have been reported (via 13F filing form) to have a value of $63.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
227
shares
|
$197
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
166
shares
|
$144
0.0% of portfolio
|
Q4 2024
Reduced 4.05%
|
|
|
Retirement Group, LLC
|
Apr 30, 2024 Q1 2024 |
155
shares
|
$134
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
113
shares
|
$98
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|